Medication Updates in Women's Health
Samantha E. Mannion, MD

LEARNING OBJECTIVES​​​​​​

• •Introduction to GIM fellowship program
  •Review mechanism of action, risks and benefits, and prescribing information for fezolinetant, a new medication for hot flashes
  •Review the two FDA-approved options for treatment of hypoactive sexual desire disorder in women, flibanserin and bremelanotide

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.